Reaction
Adenocarcinoma Metastatic reporting signals
As of the last recalculation, Adenocarcinoma Metastatic appears in 193 FAERS reports alongside 4 co-occurring drug terms. The strongest observed disproportionality signal is PANITUMUMAB (PRR 103.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Panitumumab | 14 | 103.8 | 103.9 |
| Crizotinib | 6 | 52.5 | 52.5 |
| Irinotecan Hydrochloride | 5 | 43.0 | 43.0 |
| Aflibercept | 8 | 28.8 | 28.8 |